Partial restoration of hair growth in the DEBR model for Alopecia areata after in vivo depletion of CD4+ T cells. NLM AIDSLINE Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Partial restoration of hair growth in the DEBR model for Alopecia areata after in vivo depletion of CD4+ T cells.

Br J Dermatol. 1999 Mar;140(3):432-7. Unique Identifier : AIDSLINE MED/99249991
McElwee KJ; Spiers EM; Oliver RF; Department of Biological Sciences, University of Dundee, Dundee,; DD1 4HN, U.K.


Abstract: Alopecia areata (AA) is widely believed to be an autoimmune disease. Hair loss is associated with a peri- and intrafollicular inflammatory infiltrate of anagen hair follicles primarily composed of CD4 + and CD8 + cells. A previous investigation involved in vivo depletion of CD8 + cells in the DEBR rat model to examine the cells' potential pathogenic activity in AA. The rat model is used here in a comparable study of CD4 + cell pathogenic activity. Eight AA affected DEBR rats were given intraperitoneal injections of a CD4 + cell depleting OX-35/OX-38 monoclonal antibody (MoAb) cocktail over a 15-day therapy course. A further eight AA-affected rats comprised a control group and were injected with equivalent volumes of an irrelevant MoAb, OX-21. Changes in both CD4 + and CD8 + peripheral blood cell populations were analysed by flow cytometry, and macrophotography was used to record any changes in hair growth. Of the eight CD4 + cell-depleted rats six responded with hair growth. The rats revealed significant hair growth within 23 days of treatment initiation. With rapid replacement of the CD4 + cell population the newly generated pelage hair was eventually lost. Two control rats also showed limited hair growth within the 112-day study period. In vivo depletion of CD4 + cells partially restores hair growth in AA affected rats. The response suggests that CD4 + cells may be actively involved in the pathogenesis of AA. Further research may elucidate whether CD4 + cells have a direct effect on hair follicles or exert their influence through their classic T helper cell supporting role for CD8 + cells.


Keywords: JOURNAL ARTICLE Alopecia Areata/*IMMUNOLOGY/THERAPY Animal Antibodies, Monoclonal/IMMUNOLOGY Autoimmune Diseases/*IMMUNOLOGY/THERAPY CD4 Lymphocyte Count *CD4-Positive T-Lymphocytes/IMMUNOLOGY CD8-Positive T-Lymphocytes/IMMUNOLOGY Female Flow Cytometry Hair/GROWTH & DEVELOPMENT Hair Follicle/IMMUNOLOGY Male Rats Support, Non-U.S. Gov't

KWDjournalarticlealopeciaareata/KWDimmunology/therapyanimalantibodies,monoclonal/immunologyautoimmunediseases/KWDimmunology/therapycd4lymphocytecountKWDcd4-positivet-lymphocytes/immunologycd8-positivet-lymphocytes/immunologyfemaleflowcytometryhair/growth&developmenthairfollicle/immunologymaleratssupport,non-uKWDsKWDgov't
000630
A0062004


Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .